Yang, Yi https://orcid.org/0000-0003-1575-5257
Prajapati, Prachi
Ramachandran, Sujith
Bhattacharya, Kaustuv
Bazzazzadehgan, Shadi
Maharjan, Shishir
Eriator, Ike
Bentley, John P.
Funding for this research was provided by:
National Institute on Drug Abuse (R15DA046036)
Article History
Received: 15 March 2024
Accepted: 27 March 2025
First Online: 22 April 2025
Declarations
:
: Dr Yang received a subcontract for Jackson Heart Study (NIH – NHLBI). Dr Ramachandran received grants from the AMCP Foundation, Pharmacy Quality Alliance, and Mississippi Division of Medicaid; consulted for Pharmacy Quality Alliance and served as a co-chair of the Quality Measure Expert Panel, Pharmacy Quality Alliance. Dr Bhattacharya received a subcontract from Jackson Heart Study (NIH – NHLBI); received contracts from the Mississippi State Department of Health and Mississippi Division of Medicaid and served as a member engagement co-chair in the Real World Evidence Special Interest Group at the International Society for Pharmacoeconomics and Outcomes Research. Dr Eriator received support for attending a National Science Foundation meeting. Dr Bentley received a contract from the Mississippi State Department of Health and consulted for Pharmacy Quality Alliance. All other authors report no conflicts of interests for this work.